Literature DB >> 9725209

Vaccination with BV8S2 protein amplifies TCR-specific regulation and protection against experimental autoimmune encephalomyelitis in TCR BV8S2 transgenic mice.

H Offner1, K Adlard, B F Bebo, J Schuster, G G Burrows, A C Buenafe, A A Vandenbark.   

Abstract

TCR determinants overexpressed by autopathogenic Th1 cells can naturally induce a second set of TCR-specific regulatory T cells. We addressed the question of whether immune regulation could be induced naturally in a genetically restricted model in which a major portion of TCR-specific regulatory T cells expressed the same target TCR BV8S2 chain as the pathogenic T cells specific for myelin basic protein (MBP). We found vigorous T cell responses to BV8S2 determinants in naive mice that could be further potentiated by vaccination with heterologous BV8S2 proteins, resulting in the selective inhibition of MBP-specific Th1 cells and protection against experimental encephalomyelitis. Moreover, coculture with BV8S2-specific T cells or their supernatants reduced proliferation, IFN-gamma secretion, and encephalitogenic activity of MBP-specific T cells. These results suggest that immune regulation occurs through a nondeletional cytokine-driven suppressive mechanism.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9725209

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  T-cell based immunotherapy in experimental autoimmune encephalomyelitis and multiple sclerosis.

Authors:  Kate O'Brien; Bruno Gran; Abdolmohamad Rostami
Journal:  Immunotherapy       Date:  2010-01       Impact factor: 4.196

Review 2.  Critical evaluation of regulatory T cells in autoimmunity: are the most potent regulatory specificities being ignored?

Authors:  Arthur A Vandenbark; Halina Offner
Journal:  Immunology       Date:  2008-09       Impact factor: 7.397

3.  Treatments targeting the T cell receptor (TCR): effects of TCR peptide-specific T cells on activation, migration, and encephalitogenicity of myelin basic protein-specific T cells.

Authors:  H Offner; R Jacobs; B F Bebo; A A Vandenbark
Journal:  Springer Semin Immunopathol       Date:  1999

4.  Regulatory T cells play a role in T-cell receptor CDR2 peptide regulation of experimental autoimmune encephalomyelitis.

Authors:  Abigail C Buenafe; Shayne Andrew; Halina Offner; Arthur A Vandenbark
Journal:  Immunology       Date:  2012-02       Impact factor: 7.397

Review 5.  TCR peptide therapy in human autoimmune diseases.

Authors:  A A Vandenbark; E Morgan; R Bartholomew; D Bourdette; R Whitham; D Carlo; D Gold; G Hashim; H Offner
Journal:  Neurochem Res       Date:  2001-06       Impact factor: 3.996

6.  Estrogen potentiates treatment with T-cell receptor protein of female mice with experimental encephalomyelitis.

Authors:  H Offner; K Adlard; A Zamora; A A Vandenbark
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

7.  Prevention and treatment of experimental autoimmune encephalomyelitis with clonotypic CDR3 peptides: CD4(+) Foxp3(+) T-regulatory cells suppress interleukin-2-dependent expansion of myelin basic protein-specific T cells.

Authors:  Abigail C Buenafe; Shayne Andrew; Michael Afentoulis; Halina Offner; Arthur A Vandenbark
Journal:  Immunology       Date:  2010-01-06       Impact factor: 7.397

Review 8.  Vaccines for multiple sclerosis: progress to date.

Authors:  Jorge Correale; Mauricio Farez; Wendy Gilmore
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 9.  Tolerance and autoimmunity in TCR transgenic mice specific for myelin basic protein.

Authors:  J Goverman
Journal:  Immunol Rev       Date:  1999-06       Impact factor: 12.988

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.